Cytokine · 2011 · 246 citations · 29 references
Life SciencesImmunologyMolecular BiologyClinical ImmunologyImmunopathologyMolecular ImmunologyAntibody CharacterizationAntigen Detection AssaysCancer ImmunotherapyImmunoassay DevelopmentPd-l1 BlockadeProgrammed Cell Death Protein 1 (Pd-1) PathwayProgrammed Death-ligand 1 Biomarker
29
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
Yvette Latchman, Clive R. Wood, Tatyana Chernova et al. · Nature Immunology · 2001 · 2.9K citations